Arecor is ‘advancing today’s therapies to enable healthier lives’ by developing a broad portfolio of therapies for its proprietary pipeline and in partnership with leading pharmaceutical and biotech companies
Investors are placing bets on a small British biotech to rival big pharma as it pushes its first diabetes drug through clinical trials